We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+8.84%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$212B
AUM Growth
+$25.4B
Cap. Flow
+$11.1B
Cap. Flow %
5.24%
Top 10 Hldgs %
35.63%
Holding
5,234
New
558
Increased
1,559
Reduced
2,300
Closed
327

Sector Composition

Rank Sector Weight
1 Technology 13.39%
2 Financials 7.95%
3 Communication Services 5.87%
4 Consumer Discretionary 5.85%
5 Healthcare 5.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DYAI icon
4076
Dyadic International
DYAI
$38.3M
$51K ﹤0.01%
14,269
-9,400
-40% -$39.4K
ICAD
4077
DELISTED
iCAD Inc
ICAD
$51K ﹤0.01%
2,928
-13,878
-83% -$243K
RM icon
4078
Regional Management Corp
RM
$301M
$51K ﹤0.01%
1,089
-6,064
-85% -$263K
SABA
4079
Saba Capital Income & Opportunities Fund II
SABA
$220M
$51K ﹤0.01%
4,350
-12,484
-74% -$138K
SPGP icon
4080
Invesco S&P 500 GARP ETF
SPGP
$2.25B
$51K ﹤0.01%
+584
New +$50K
STIM icon
4081
Neuronetics
STIM
$138M
$51K ﹤0.01%
3,159
-1,939
-38% -$26.8K
APRN
4082
CALL
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$51K ﹤0.01%
1,000
RAD
4083
PUT
DELISTED
Rite Aid Corporation
RAD
$51K ﹤0.01%
+3,100
New +$59.3K
HWBK icon
4084
Hawthorn Bancshares
HWBK
$269M
$50K ﹤0.01%
2,369
-3,128
-57% -$62.8K
RCKY icon
4085
Rocky Brands
RCKY
$366M
$50K ﹤0.01%
891
-4,849
-84% -$273K
SGA icon
4086
Saga Communications
SGA
$57M
$50K ﹤0.01%
2,340
-828
-26% -$18.2K
TEO icon
4087
Telecom Argentina
TEO
$6.03B
$50K ﹤0.01%
9,334
+1,456
+18% +$7.67K
CLVS
4088
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
$50K ﹤0.01%
8,700
TREC
4089
DELISTED
Trecora Resources
TREC
$50K ﹤0.01%
5,973
-14,223
-70% -$114K
RESN
4090
DELISTED
Resonant Inc.
RESN
$50K ﹤0.01%
15,783
-34,051
-68% -$117K
AEO icon
4091
PUT
American Eagle Outfitters
AEO
$2.88B
$49K ﹤0.01%
1,300
APLT
4092
DELISTED
Applied Therapeutics
APLT
$49K ﹤0.01%
2,330
-10,725
-82% -$203K
CZNC icon
4093
Citizens & Northern Corp
CZNC
$456M
$49K ﹤0.01%
1,965
-9,194
-82% -$226K
SLX icon
4094
VanEck Steel ETF
SLX
$169M
$49K ﹤0.01%
+793
New +$48.6K
URG
4095
Ur-Energy
URG
$485M
$49K ﹤0.01%
35,172
+29,206
+490% +$39.9K
XPH icon
4096
State Street SPDR S&P Pharmaceuticals ETF
XPH
$476M
$49K ﹤0.01%
944
+844
+844% +$42.4K
SEI
4097
Solaris Energy Infrastructure
SEI
$3.15B
$49K ﹤0.01%
4,969
-21,940
-82% -$232K
ZYNE
4098
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$49K ﹤0.01%
9,211
+8,472
+1,146% +$40.7K
ALCO icon
4099
Alico
ALCO
$280M
$48K ﹤0.01%
1,345
-3,014
-69% -$95.3K
BCBP icon
4100
BCB Bancorp
BCBP
$173M
$48K ﹤0.01%
3,577
-8,438
-70% -$117K

Similar funds

Barclays's Q2 2021 Portfolio in Review

As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.

  • Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
  • Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
  • Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
  • Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
  • Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
  • Barclays opened 558 new positions and closed 327 in Q2 2021.
  • Barclays's portfolio value rose 14% quarter-over-quarter to $212B.

Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.